A Bertrand

1.3k total citations · 1 hit paper
8 papers, 965 citations indexed

About

A Bertrand is a scholar working on Surgery, Genetics and Oncology. According to data from OpenAlex, A Bertrand has authored 8 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Genetics and 2 papers in Oncology. Recurrent topics in A Bertrand's work include Blood properties and coagulation (1 paper), Bone health and treatments (1 paper) and Diabetes and associated disorders (1 paper). A Bertrand is often cited by papers focused on Blood properties and coagulation (1 paper), Bone health and treatments (1 paper) and Diabetes and associated disorders (1 paper). A Bertrand collaborates with scholars based in France, United States and India. A Bertrand's co-authors include Marie Kostine, Thomas Barnetche, Thierry Schaeverbeke, Marie‐Elise Truchetet, Donald P. Quick, Peter J. Ell, F. R. Ahmann, Robert H. Reid, A. N. Serafini and R A Lerski and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Pediatrics and BMC Medicine.

In The Last Decade

A Bertrand

8 papers receiving 945 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

2015 540 citations A Bertrand, Marie Kostine et al. BMC Medicine profile →

Peers

Countries citing papers authored by A Bertrand

Since Specialization

Citations

This map shows the geographic impact of A Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Bertrand more than expected).

Fields of papers citing papers by A Bertrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Bertrand. The network helps show where A Bertrand may publish in the future.

Co-authorship network of co-authors of A Bertrand

This figure shows the co-authorship network connecting the top 25 collaborators of A Bertrand. A scholar is included among the top collaborators of A Bertrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Bertrand. A Bertrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry 2023 ·Lara D. Veeken ·(unknown), A Bertrand, (unknown), Jérôme Avouac, Éric Toussirot, Fabienne Coury, Raphaèle Séror, (unknown), (unknown), (unknown), (unknown), Cyrille Hulin, Clément Prati, Thierry Schaeverbeke, Christophe Richez, Marie‐Elise Truchetet, Marie Kostine	1
2	Postauthorization safety study of Clottafact^®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study 2017 ·Vox Sanguinis ·Claude Négrier, A.‐S. Ducloy‐Bouthors, Vincent Piriou, Emmanuel de Maistre, Natalie Stieltjes, Annie Borel‐Derlon, P Colson, Julien Picard, Thierry Lambert, S. Claeyssens, (unknown), A Bertrand, (unknown), F. Fourrier, Yves Ozier, Piérre Siè, Yves Gruel, Z. Tellier	8
3	Post‐authorization safety study of Clottafact^®, a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study 2016 ·Vox Sanguinis ·Claude Négrier, C. Rothschild, J.Y. Borg, Thierry Lambert, S. Claeyssens, Laurence Sanhès, Natalie Stieltjes, A Bertrand, (unknown), Piérre Siè, Yves Gruel, Z. Tellier	16
4	Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis breakdown → 2015 ·BMC Medicine ·A Bertrand, Marie Kostine, Thomas Barnetche, Marie‐Elise Truchetet, Thierry Schaeverbeke	540
5	Screening of LHX2 in patients presenting growth retardation with posterior pituitary and ocular abnormalities 2012 ·European Journal of Endocrinology ·(unknown), Florence Dastot‐Le Moal, Nathalie Collot, Marie Legendre, Isabelle Abadie, A Bertrand, Serge Amselem, Marie‐Laure Sobrier	8
6	Neonatal diabetes mellitus: Chromosomal analysis in transient and permanent cases 2002 ·The Journal of Pediatrics ·Chantal Metz, Hélène Cavé, A Bertrand, Christine Deffert, (unknown), Paul Czernichow, Michel Polak	76
7	Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. 1998 ·Journal of Clinical Oncology ·A. N. Serafini, (unknown), I. Resche, Donald P. Quick, Frank Grund, Peter J. Ell, A Bertrand, F. R. Ahmann, Eduardo Orihuela, Robert H. Reid, R A Lerski, B. David Collier, J. H. McKillop, Gary L. Purnell, A Pecking, (unknown), Katherine Harrison	310
8	[On the antibiotic therapy of typhoid fever. Comments on 90 cases treated by thiamphenicol]. 1966 ·PubMed ·(unknown), A Bertrand, (unknown), Frédéric S. Michel	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact